Abiopharma

Apollo Adds Senior Policy and Government Affairs Leaders in Europe

Applied Materials Expands Singapore Manufacturing to Support AI Chip Demand

Press Release: Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy

TGS Begins First Phase of Major Offshore Seismic Dataset in Equatorial Guinea

Communiqué de presse : Sanofi fait le point sur l’étude de phase 3 MOBILIZE, qui évalue le riliprubart dans la polyneuropathie inflammatoire démyélinisante chronique

Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering

Equity Listing - Ordinary Shares: Allotment and Issue of 2,500,000 New Shares Pursuant to Exercise of Warrants

General Announcement: Net Asset Value ("NAV") as of 09 June 2026

Asset Acquisitions and Disposals: RECEIPT OF WHITEWASH WAIVER FROM THE SECURITIES INDUSTRY COUNCIL

Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering